MedPath

A clinical study to find out the effect of homoeopathic medicines in the management of Depression along with supportive counseling

Phase 2
Conditions
Health Condition 1: F320- Major depressive disorder, singleepisode, mildHealth Condition 2: F321- Major depressive disorder, singleepisode, moderate
Registration Number
CTRI/2023/12/060416
Lead Sponsor
Dr K Madhavi Priyanka
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Age group between 18-60 yrs of both sexes

2. Patient presenting with symptoms of mild and moderate depressive disorder for at least

2 weeks duration and fulfilling the diagnostic criteria of DSM-V

3. Patients with Becks depression inventory score between 17-30

Exclusion Criteria

1. Patients having suicidal ideation with a history of attempted suicide.

2. Patients with severe depressive disorders taking anti depressants and antipsychotics.

3. Any other psychiatric co morbidities

4. Alcohol abuse/any serious physical illness using conventional treatment.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The Hamilton Depression Rating Scale (HDRS) will be assessed every month. The outcome measurement will be done by comparing the Hamilton Depression Rating Scale scores of subjects of both group A and group B at baseline, 3rd month and 6th monthTimepoint: 6 months
Secondary Outcome Measures
NameTimeMethod
The WHO QOL- BREF scale will be assessed at the baseline and 6th month of the study.Timepoint: 6 months
© Copyright 2025. All Rights Reserved by MedPath